Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension

被引:60
作者
Sondermeijer, B
Kompa, A
Komesaroff, P
Krum, H
机构
[1] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3004, Australia
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
urotensin-II; hypertension; microcirculation; iontophoresis; laser Doppler velocimetry; pharmacology;
D O I
10.1016/j.amjhyper.2005.03.748
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Plasma levels of urotensin-II (U-II) have been found to be elevated in patients with essential hypertension. However, the consequence of activation of the U-II system have not been previously determined in these patients. We therefore compared the effect of exogenous U-II administration on vascular tone in hypertensive patients (n = 13) and normotensive subjects (n = 14). Methods: The effect of U-II on vascular tone was determined in the forearm skin microcirculation using iontophoresis to administer the drug and laser Doppler velocimetry to measure microvascular response. Results: The U-II administration was associated with a dose-dependent vasodilator response from baseline in normotensive subjects (U-II 1 X 10(-12) mol/L, 609 +/- 164; U-II 1 X 10(-9) mol/L, 839 +/- 216; U-II, 1 X 10(-7) mol/L, 1249 +/- 228 arbitrary flux units; P < .0005). A dose-dependent vasoconstrictor response was observed in hypertensive patients compared to baseline (U-II 1 X 10(-12) mol/L, 60 +/- 212; U-II 1 X 10(-9) mol/L, -288 +/- 172; U-II, 1 X 10(-7) mol/L, -607 +/- 165 arbitrary flux units; P < .005). Differences in flow between the two groups were significant at the 1 X 10(-9) mol/L and 1 X 10(-7) mol/L dose levels (P < .001). In contrast, there was no significant difference in flux between baseline and U-II in either group (or between groups) when the opposite polarity was applied. Conclusions: The demonstration of opposing effects of exogenous U-II in patients with hypertension and normal subjects suggests that U-II may be contributory to the increased vascular tone of these patients.
引用
收藏
页码:1195 / 1199
页数:5
相关论文
共 29 条
  • [1] Urotensin II: a new mediator in cardiopulmonary regulation?
    Affolter, J
    Webb, DJ
    [J]. LANCET, 2001, 358 (9284) : 774 - 775
  • [2] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    [J]. NATURE, 1999, 401 (6750) : 282 - 286
  • [3] Urotensin-II: a novel systemic hypertensive factor in the cat
    Behm, DJ
    Doe, CPA
    Johns, DG
    Maniscalco, K
    Stankus, GP
    Wibberley, A
    Willette, RN
    Douglas, SA
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (03) : 274 - 280
  • [4] Urotensin II evokes potent vasoconstriction in humans in vivo
    Böhm, F
    Pernow, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) : 25 - 27
  • [5] Effects of human urotensin II in isolated vessels of various species;: comparison with other vasoactive agents
    Camarda, V
    Rizzi, A
    Calò, G
    Gendron, G
    Perron, SI
    Kostenis, E
    Zamboni, P
    Mascoli, F
    Regoli, D
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (02) : 141 - 149
  • [6] Plasma concentration of urotensin II is raised in hypertension
    Cheung, BMY
    Leung, R
    Man, YB
    Wong, LYF
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 (07) : 1341 - 1344
  • [7] Conlon JM, 1996, J EXP ZOOL, V275, P226, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<226::AID-JEZ14>3.0.CO
  • [8] 2-H
  • [9] Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord
    Coulouarn, Y
    Lihrmann, I
    Jegou, S
    Anouar, Y
    Tostivint, H
    Beauvillain, JC
    Conlon, JM
    Bern, HA
    Vaudry, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15803 - 15808
  • [10] From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function
    Douglas, SA
    Dhanak, D
    Johns, DG
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (02) : 76 - 85